Drug · DIN 02426838
DOCUSATE SODIUM
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 16, 2014; first marketed July 16, 2014.
- Drug Identification Number (DIN)
- 02426838
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Docusate sodium A06AA02
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DOCUSATE SODIUM | 100 MG |
Other DINs named DOCUSATE SODIUM
- DIN 00870218 · Cancelled Post Market
- DIN 02246036 · Cancelled Post Market
- DIN 02246854 · Cancelled Post Market
- DIN 02289873 · Dormant
- DIN 02326086 · Cancelled Post Market
- DIN 02417863 · Cancelled (Unreturned Annual)
- DIN 02437325 · Cancelled Pre Market
- DIN 02464608 · Cancelled Pre Market
- DIN 02492644 · Approved
- DIN 02500922 · Approved